Lilly To Cut Some List Prices By 70% And Offer $25 Insulin
Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly prescribed insulin products, Humalog and Humulin, beginning from the fourth quarter of this year.
Source: ibtimes.com